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Purpose: We undertook this study to document the functional natural history of patients undergoing major amputation
in an academic vascular surgery and rehabilitation medicine practice.
Methods: A retrospective review was conducted of consecutive patients undergoing major lower extremity amputation and
rehabilitation in a university and Department of Veterans Affairs hospital. Main outcome variables included operative
mortality, follow-up, survival, median time to incision healing, secondary operative procedures for wound management,
and conversion from below-knee amputation (BKA) to above-knee amputation (AKA). For surviving patients, quality of
life was determined by degree of ambulation, eg, outdoors, indoors only, or no ambulation; use of a prosthesis; and
independence, eg, community housing or nursing facility.
Results: From August 1997 through March 2002, 154 patients (130 men; median age, 62 years) underwent 172 major
amputations, 78 AKA and 94 BKA, because of either critical limb ischemia (87%) or diabetic neuropathy (13%).
Thirty-day operative mortality was 10%. Mean follow-up was 14 months. Healing at 100 and 200 days, as determined
with the Kaplan-Meier method, was 55% and 83%, respectively, for BKA, and 76% and 85%, respectively, for AKA.
Twenty-three BKA and 16 AKA required additional operative revision, and 18 BKA ultimately were converted to AKA.
Survival was 78% at 1 year and 55% at 3 years. Function in surviving patients at 10 and 17 months, respectively, was as
follows: 21% and 29% of patients ambulated outdoors, 28% and 25% ambulated indoors only, and 51% and 46% of
patients were nonambulatory; 32% and 42% of patients used prosthetic limbs; and 17% and 8% of patients who lived in
the community before amputation required care in a nursing facility.
Conclusions: We were surprised to find that vascular patients in a contemporary setting who require major lower extremity
amputation and rehabilitation often remain independent despite infrequent prosthesis use and outdoor ambulation.
Although any hope for postoperative ambulation in this population requires salvaging the knee joint, because of the
morbidity incurred in both wound healing and rehabilitation efforts, aggressive effort should be reserved for selected
patients at good risk. Ability to predict ambulation after BKA in the vascular population is poor. (J Vasc Surg 2003;38:
7-14.)
Most vascular surgeons approach critical limb ischemia
in neurologically intact patients with the goal to save as
much limb length as possible. Digit amputation is preferred
over ray amputation, transmetatarsal amputation is pre-
ferred over below-knee amputation (BKA), and BKA is
preferred over above-knee amputation (AKA). However,
significant technical difficulty and patient morbidity are
associated with incision of any type distal to the knee joint
in patients with critical limb ischemia.1-4 The motivation
for efforts to salvage the knee joint in patients in whom
amputation is necessary has been the lesser energy expen-
diture associated with prosthetic use after healed BKA
compared with AKA.5 Inability to ambulate was presumed
to necessitate long-term nursing care for most patients with
critical limb ischemia.6 Ambulation is an important postop-
erative goal after major lower extremity amputation for
patients and physicians alike.
With a population that is aging, increasingly obese, and
with significant comorbid conditions, ubiquitous ambula-
tion for all patients with major lower extremity amputation
may be impractical. Since passage of the Americans with
Disabilities Act in 1990,7 the environment into which
amputees must assimilate has changed markedly. Tradi-
tional arguments for preserving maximum limb length may
be invalid. At both our university hospital and Department
of Veterans Affairs Medical Center, we have a modern
rehabilitation service that aggressively pursues postopera-
tive ambulation for patients without neurologic impair-
ment or dementia. We have developed a database that
permits collection of multiple clinical variables and func-
tional outcome in this population. Analysis of comorbid
conditions and functional results of major lower extremity
amputation on the vascular service at our two hospitals
forms the basis of this report.
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MATERIAL AND METHODS
At the University of Colorado Health Sciences Center
and the Denver Veterans Affairs Medical Center, vascular
surgeons perform most major lower extremity amputa-
tions. No standard preoperative vascular evaluation other
than physical examination to assess for presence of a femo-
ral pulse and normal calf skin temperature for below-knee
healing, and clinical judgment as to whether postoperative
ambulation would be probable, considering comorbid con-
ditions including obesity, cardiopulmonary disease, and
preoperative ambulatory status, is used to determine level
of amputation. Most AKAs were performed on the basis of
poor functional prognosis rather than poor healing poten-
tial. However, some patients considered not significant
ambulatory candidates refused primary AKA and under-
went BKA. The Burgess technique8 was used for BKA. Use
of immediate protective casting varied among the three
attending surgeons. Protective casts were placed on all
limbs operated on in patients referred for rehabilitation
medicine in the immediate postoperative period, provided
they had no open wounds. Our rehabilitation service ag-
gressively pursues some level of ambulation in all patients
without dementia or neurologic impairment.
In December 1998, with initial grant funding from The
Hartford Foundation, we created a Health Insurance Port-
ability and Accountability Act (HIPAA)9–compliant Inter-
net-based comprehensive database (MedXchange, Tampa,
Fla) regarding functional outcome in patients with critical
limb ischemia at the University of Colorado Health Sci-
ences Center and Denver Veterans Affairs Medical Center.
The initial plan was to track patients undergoing lower
extremity revascularization; however, the database quickly
became a tool to track all patients seen at both hospitals
with critical limb ischemia, as defined by Reporting Stan-
dards, or foot lesions due to diabetic neuropathy. The data
were both prospectively and retrospectively entered into
the database.
The database is relational, with multiple forms linked to
a patient identification number. A password-protected key
with patient identifiers housed locally is used to correlate
identification numbers on the Internet database to patients
allowing HIPAA-compliant data entry. Data collected at
enrollment include demographics, comorbid conditions,
and previous vascular procedures. Data related to comor-
bidity were collected from the diagnosis in the problem list
of the admission history and physical examination or the
discharge summary. The remainder of the data were en-
tered multiple times per patient, categorized by date to
allow longitudinal collection of events and outcome. Pa-
tient variables include symptoms (duration before presen-
tation, rest pain or necrosis, and details of any major adverse
antecedent events in the 6 months before presentation to
the vascular surgeon that may have contributed to eventual
limb loss), foot lesions (categorization of extent of foot
necrosis at presentation), laboratory values, blood pressure,
weight, hospitalization history (admission and discharge
dates, discharge status with regard to independence and
ambulation, complications, and all operative procedures),
and follow-up (incision healing, independence and ambu-
lation, prosthesis use, and significant adverse medical and
functional events).
Statistical analysis. Data were analyzed with SAS
software (SAS, Cary, NC), broken down into demograph-
ics, hospital care, and outcome. Patient or symptom demo-
graphic data included age, gender, comorbidity (from the
medical history), body mass index [BMI], previous vascular
procedures, baseline laboratory values (hematocrit, albu-
min concentration), duration of symptoms before vascular
surgical evaluation, and type of symptoms (rest pain, necro-
sis). Details of the 6-month history before referral for
vascular surgery included any major adverse event that
precipitated or contributed to the presenting problem that
led to amputation.
Limb lesion demographics included a detailed descrip-
tion of the nature of necrotic lesions, including extent of
the necrotic process based on findings at physical examina-
tion at initial presentation. Necrotic extent was categorized
as forefoot (single versus multiple sites and digit-limited
versus involvement of the metatarsal head, and location of
more proximal lesions), malleolar, midfoot, heel, and
global. Lesions were classified as ulceration, dry gangrene,
or sepsis, with the most severe process involved predomi-
nating. For example, clinical wet gangrene would be cate-
gorized as sepsis, with the understanding that differentia-
tion between the two is not always clear at physical
examination alone. However, limb salvage decisions are
made in part on the basis of findings at physical examination
of the foot, because foot imaging can be innacurate10 and
in this series was not uniformly performed because of the
variety of processes and extent of lesions, and the classifica-
tion system was designed to reflect this.
Hospital care data included length of stay, details re-
garding amputation (guillotine, BKA, AKA, and wound
debridement), and in-hospital complications. Longitudinal
functional outcome included time to incision healing, need
for additional operations, conversion of BKA to AKA,
incidence over time of prosthesis use, ambulation status,
and independence. For these analyses, BKA and AKA
groupings were made on an intention to treat basis. There-
fore the BKA group included surviving patients who first
underwent BKA, and therefore included some patients who
eventually underwent conversion to AKA. The final three
functional outcome items were grouped at 6-month and
12-month intervals. These were defined as the first fol-
low-up data identified 6 or more months and 12 or more
months after the amputation date for each surviving pa-
tient. Therefore the data represent mean follow-up data for
all patients at 10.3 and 17.5 months, because the study
included no specific follow-up intervals. In addition, sub-
group analysis of function was performed in patients who
were nonambulatory at baseline, patients with mental ill-
ness or substance abuse, and age stratified at 75 years.
Data were summarized descriptively with frequency
and percentage of patients or procedures, as appropriate,
for categorical end points such as gender, risk factors,
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complications, and functional outcome. Continuous end
points such as age, BMI, and albumin concentration were
summarized as mean, standard deviation, and percentile.
Comparisons between baseline comorbidity and functional
outcome categories for patients with BKA versus AKA were
performed with the 2 test. Patient survival and time to
incision healing were determined with the Kaplan-Meier
method. P  .05 was considered statistically significant.
RESULTS
From August 1, 1997, through March 2, 2002, 154
patients (130 men; median age, 62 years; 90 from the
Veterans Affairs Medical Center) underwent major lower
extremity amputation. Clinical data for these patients are
presented in Table I, and laboratory values are presented in
Table II. Variables that differed significantly between pa-
tients with BKA and AKA, respectively, were congestive
heart failure (18% vs 35%; P  .02), diabetes (72% vs 56%;
P  .03), renal replacement (19% vs 3%; P  .004), and
previous myocardial infarction (20% vs 35%; P  .04).
Forty-seven patients (30%) had some history of claudica-
tion. Previous vascular procedures at presentation included
one or more revascularization procedures in 41 patients
(27%), involving the present symptomatic limb in 90%.
Forty patients (26%) had undergone one or more previous
minor amputations, involving the present symptomatic
limb in 78%. Twenty-three patients (15%) had undergone a
previous contralateral major lower extremity amputation.
In the 6 months before vascular surgery consultation, 38
patients (25%) had one or more major adverse events (n 
44) that contributed in part to eventual limb loss. The most
common event was graft occlusion (n  15); other major
events included myocardial infarction (n  6), major frac-
ture (n  11), stroke (n  4), ruptured abdominal aortic
aneurysm (n  3), burn trauma (n  2), coronary artery
bypass vein harvest (n  2), and lower extremity arterial
graft infection (n 1). Mean duration of symptoms before
vascular consultation was far less for patients with rest pain
(27  55 days) than for patients with foot necrosis (73 
82 days).
At presentation, 87% of patients (n  134) had critical
limb ischemia and 13% of patients (n  20) had complica-
tions of diabetic neuropathy. Details of foot lesions in the
patients with necrosis are presented in Table III. At initial
evaluation, 62 patients were considered candidates for re-
vascularization. However, 25 patients eventually under-
went amputation, despite patent bypass grafts or successful
interventions (17 surgical, 8 percutaneous transluminal
angioplasty [PTA]), because of ongoing foot ischemia; 21
patients eventually underwent amputation after reconstruc-
tion (20 surgical, 1 PTA), because of occlusion or infection;
10 patients had no acceptable distal target for bypass graft-
ing, as demonstrated on arteriograms; and 6 patients even-
tually underwent amputation because of deterioration in
medical status before revascularization. Minor amputation
was performed in 7 patients, without arteriography, be-
cause of limited foot lesions, normal arterial circulation at
noninvasive evaluation, or significant comorbidity that pre-
cluded revascularization. The remaining 85 patients under-
went primary major lower extremity amputation because of
poor functional status, significant comorbidity, extensive
foot necrosis, or a combination of these factors. No differ-
ence was noted in preoperative variables between patients
who underwent primary amputation and those who under-
went revascularization or minor amputation. During the
same 5-year period, 165 patients underwent surgical revas-
cularization to treat critical limb ischemia.
One hundred seventy-two major lower extremity am-
putations were performed (78 AKA, 94 BKA; 14 BKA were
initial guillotine amputations). Median hospital stay was 14
days. Thirty-four patients had one or more complications;
the most frequently occurring are listed in Table IV. Peri-
Table I. Baseline medical comorbidity and functional
variables in patients undergoing major lower extremity
amputation
Risk factor n %
Medical (N  153*)
Diabetes 100 65
Coronary artery disease 60 39
Previous MI 40 26
CHF 38 25
Previous CABG 24 16
Smokers 131 86
Current 73 48
Stroke 22 14
COPD 23 18
O2 dependent 4 3
Renal replacement 27 18
Functional (N  153*)
Mental illness 25 16
Substance abuse 54 35
Total hip arthroplasty 9 6
Independence (N  154)
Community living 134 87
Care facility resident 20 13
Ambulation (N  154)
Nonambulatory 25 16
Indoors only 23 15
Outdoors 106 69
MI, Myocardial infarction; CHF, congestive heart failure; CABG, coronary
artery bypass graft; COPD, chronic obstructive pulmonary disease.
*Data not available for one patient.
Table II. Baseline laboratory values in patients
undergoing major lower extremity amputation
Value Mean SD
25th
percentile
75th
percentile
Albumin*
(Gmg/dL)
2.4 0.7 1.9 2.9
Hematocrit† (%) 33.2% 5.7 29.1 37.4
BMI‡ 25 5.7 20.9 28.1
*Value closest to date of amputation or initial vascular evaluation 30 days;
available for 101 patients.
†Preoperative value closest to amputation date within 30 days; available for
97 patients.
‡Body mass index before amputation; available for 118 patients.
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operative mortality was 10.4%; fatal complications are listed
in Table V. Mean follow-up was 14 months. Eighteen
patients (11%) were lost to follow-up at a mean of 7.4
months. Incision healing is illustrated in the Figure. At 100
days, 55% of BKA were healed, compared with 76% of AKA.
At 200 days, 83% of BKA and 85% of AKA were healed.
There was no linear correlation between healing rate and
baseline albumin concentration. Twenty-three BKA and 16
AKAs required additional operative revision, and 18 BKA
(19%) ultimately were converted to AKA. Seven BKA fail-
ures were in patients with acute ischemia and failed revas-
cularization, with calf muscle that was not salvaged; 11
BKA failures were in patients with chronic ischemia and
nonhealing incisions. Two patients had undergone previ-
ous revascularization procedures; 3 patients had renal fail-
ure; 2 patients had contractures; and 2 patients had persis-
tent sepsis at the level of the BKA. Patient survival was 78%
at 1 year and 55% at 3 years (Kaplan-Meier method). Major
adverse events occurred in 66 surviving patients (48%)
during follow-up; the most commonly occurring are listed
in Table V.
Functional outcome is summarized in Table VI. Inas-
much as there was no set protocol for follow-up, functional
data for 6-month and 12-month follow-up are organized in
mean time from amputation of 10.3 and 17.5 months,
respectively. Fewer than half of surviving patients used a
prosthesis, and most of these had undergone BKA. Fewer
than a third of surviving patients ambulated outdoors, and
almost all had undergone BKA. Another fourth of patients
ambulated indoors only, and a slightly greater number of
these patients had undergone BKA compared with AKA.
However, despite significantly superior rates of ambulation
and prosthesis use at 10 and 17 months in surviving pa-
tients with BKA, there was no significant difference in rate
of move from community living to a residential care facility
at either interval.
Functional outcome according to subgroup analysis is
demonstrated in Table VII. Patients who were nonambu-
latory at baseline never ambulated independently during
follow-up. Patients with substance abuse and mental illness
Table III. Details of presenting foot lesions in 132 limbs with foot necrosis in patients undergoing major lower
extremity amputation
Location
Ulceration
(N  25)
Dry gangrene
(N  56)
Sepsis
(N  51)
Total
(N  132)
n % n % n % n %
Forefoot
Digit, single 4 16 4 7 3 6 11 8
Digit, multiple 6 24 11 20 2 4 19 14
MTH, single 2 8 3 5 5 10 10 8
MTH, multiple 0 0 6 11 8 16 14 11
Malleolar 1 4 3 5 2 4 6 5
Midfoot 4 16 5 9 16 31 25 19
Heel 6 24 13 23 10 20 29 22
Global* 2 8 11 20 5 10 18 13
Categorization based on gross appearance of the foot necrosis on preoperative physical examination alone.
MTH, Metatarsal head.
*Either complete breakdown of previous amputation, extremity with large gangrenous defects, or extremity nonviable at either the foot or calf level at
presentation.
Table IV. Perioperative complications* in 154 patients
Complication
Total Fatal
n % n %
Decubitus (sacral and/
or remaining heel)
10 6.5 0 0
Pulmonary 8 5.2 3 1.9
Cardiac 12 7.8 10 6.5
Sepsis 4 2.6 2 1.3
Bleeding 3 1.9 0 0
Renal 1 0.6 1 0.6
*Data for most significant perioperative complications encountered.
Table V. Medical and functional events during
follow-up*
Event n %
Medical requiring hospitalization
Renal failure requiring dialysis 6 4.2
Sepsis 8 5.6
Cardiac† 9 6.3
Liver failure 5 3.5
Pulmonary 4 2.8
Thromboembolism 3 2.1
Stroke 2 1.4
Suicide attempt 2 1.4
Functional
Traumatic fall‡ 23 16
Major fracture 4 2.8
Noncompliance§ 6 4.2
*Data for most common events encountered over mean follow-up of 14
months in 143 amputees who survived to discharge or 30 days.
†Myocardial infarction, congestive heart failure.
‡All traumatic falls required temporary or permanent cessation of rehabili-
tation program.
§To degree prompting permanent cessation of rehabilitation program.
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at baseline had no change in ambulation, but significant
reduction in use of a prosthesis. Patients older than 75 years
rarely ambulated or used a prosthesis during follow-up.
There was no difference in prosthesis use or functional
results in patients in whom an initial attempt at revascular-
ization had been made versus those with primary amputa-
tion.
DISCUSSION
The present study challenges tradition that salvage of
the knee joint is required to maintain patient indepen-
dence. As in other reports, most amputations are necessi-
tated by complications of critical limb ischemia.11-13 Mean
duration of symptoms before presentation was often ex-
tremely long, several weeks to months, and was much
greater for patients with necrosis than for patients with
ischemic rest pain. Most patients did not describe claudica-
tion with antecedent vascular symptoms before onset of
critical limb ischemia.14 In one fourth of patients acute
adverse events contributed in part to limb loss, with graft
occlusion and major orthopedic injury the most common.
Comorbid conditions in the population were substantial,
most notably, cardiopulmonary disease, renal failure, inad-
equate nutrition, and anemia. In addition, a modest num-
ber of patients had significant antecedent functional impair-
ment, including substance abuse and mental illness.
Analysis of lower extremity amputation in this disad-
vantaged population produced both predictable and unex-
pected results. Perioperative mortality was consistent with
that in other reports.15,16 BKA-AKA ratio was roughly 1:1,
as in other major series.17-21 Healing rate for BKA was
markedly less than for AKA, with a 20% rate of eventual
conversion of BKA to AKA, also in accord with published
series.14,22-27 Survival decreased markedly over time, em-
phasizing the palliative nature of amputation. Approxi-
mately half of surviving amputees ambulated at 10 and 17
months, with half of this ambulation limited to indoors
only. Despite an aggressive rehabilitation program, only
one fourth of surviving amputees were able to walk out of
their homes. Fewer than half of patients used prostheses
during the same interval; many patients ambulated indoors
only in a limited fashion with an assist device. However,
despite the disadvantaged population and low rate of am-
bulation, few patients required an extended care facility
postoperatively when they had been living in the commu-
nity preoperatively. This would suggest that inability to
ambulate was compensated for by improved wheelchair
Healing time in 172 major lower extremity amputations, 94 below-knee and 78 above-knee (Kaplan-Meier method).
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access, enabling patients to perform activities of daily living
and remain in the community.
Table III describes new information in the literature on
critical limb ischemia. Unlike atherosclerosis in multiple
anatomic areas,28-30 there is no classification system for
foot lesions in critical limb ischemia, despite the rather
obvious implications regarding ultimate function, advis-
ability of limb salvage, and long-term morbidity. Table III
is easy to interpret. The amount of tissue involved in the
process increases as one proceeds down column 1, and the
clinical severity of the process increases as one proceeds
from left to right (accepting some limitations in completely
Table VI. Functional outcome in surviving patients* after major lower extremity amputation
Parameter
Follow-up at 10.3 months† Follow-up at 17.5 months‡
n % n %
All Patients (N  90) (N  69)
Ambulatory outdoors 19 21 20 29
Ambulatory indoors only 25 28 17 25
Nonambulatory 46 51 32 46
Prosthesis Use 29 32 29 42
Community to care facility 15 17 6 8
Below-knee amputation group (N  60) (N  48)
Ambulatory outdoors 17 28 18 38
Ambulatory indoors only 20 33 13 27
Nonambulatory 23 38 17 35
Prosthesis use 26 43 25 52
Community to care facility 9 15 3 6
Above-knee amputation group (N  30) (N  21)
Ambulatory outdoors 2 7 2 10
Ambulatory indoors only 5 17 4 19
Nonambulatory 23 77 15 71
Prosthesis use 3 10 4 19
Community to care facility 6 20 3 14
*One hundred forty-three amputees who survived to discharge or 30 days.
†Mean follow-up for 6-month group.
‡Mean follow-up for 12-month group.
Table VII. Functional outcome in patient subgroups
Parameter
Subgroup 1 Subgroup 2
Pn % n %
Mental illness and/or
substance abuse No Yes
Ambulatory outdoors 12 26.7 7 15.6 .43
Ambulatory indoors only 12 26.7 13 28.9
Nonambulatory 21 46.7 25 55.6
Prosthesis use 17 37.8 12 26.7 .26
Patients with 6-month follow-up by age
Age 75 years 75 years
Ambulatory outdoors 18 22.8 1 9.1 .09
Ambulatory indoors only 24 30.4 1 9.1
Nonambulatory 37 46.8 9 81.8
Prosthesis use 28 35.4 1 9.1 .08
Patients with  6-month follow-up, by initial therapy
Initial therapy* Primary amputation
Attempted
revascularization
Ambulatory outdoors 9 18.0 6 20.7 .95
Ambulatory indoors only 15 30.0 8 27.6
Nonambulatory 26 52.0 15 51.7
Prosthesis use 16 32.0 9 31.0 .93
*Excluding conservative therapy group.
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stratifying the various processes and extent of involvement
in a linear fashion). Therefore, the more values in the lower
right portion of the table the worse the foot necrosis in the
population and the less the likelihood for reasonable limb
salvage, regardless of the arterial circulation. In our series of
major amputations, three fourths of necrotic lesions were
either dry gangrene or sepsis, and two thirds involved the
metatarsal head or more proximal forefoot.
Because the data were collected from a Veterans Affairs
and University practice, our functional results may be crit-
icized as not applicable to other patient populations. We
disagree with this reproach. As stated, our technical results
are in accord with many other reported series in the litera-
ture. Our rate of ambulation is also similar to that in several
reports,20,31,32 particularly in view of the often vaguely
defined end point of “ambulation.” Most of our functional
outcome data are from detailed physical therapy and reha-
bilitation notes, and follow-up history and examination of
patients in the combined vascular clinics. The number of
patients with available data and percent lost to follow-up
are typical of clinical research in this area. This study pro-
vides pilot data on functional outcome of patients with
critical limb ischemia undergoing major limb amputation;
we hope it will engender larger prospective multicenter
studies of various populations to determine whether some
of our original observations are consistently accurate.
Is an end point of bipedal gait with prosthetic limbs
unrealistic for most amputees? From a physiologic stand-
point, the answer must be yes for many patients. We were
surprised to find that a history of substance abuse, poor
nutrition, and anemia, in addition to the typical comorbid
conditions in a population with critical limb ischemia,
frequently do not dissuade the rehabilitation service from
aggressively pursuing prosthetic ambulation. This philoso-
phy produced morbidity in several patients, who sustained
falls and major fractures during rehabilitation. Others were
predictably noncompliant with an arduous program de-
signed to improve strength and balance. Perhaps it is not
surprising that many frail patients faced with the choice
between such physically demanding activity and a less stren-
uous primary wheelchair existence eventually choose the
latter. Increased community wheelchair access in the last
decade may have actually promoted this shift in behavior.
In retrospect, preoperative clinical variables used to
decide whether AKA or BKA was performed were inconsis-
tent with regard to implications of function. The nature of
the foot lesions, age, preoperative BMI, albumin concen-
tration, and hematocrit were not statistically different in the
two groups (BKA vs AKA). In addition, no variables were
found to be different in the groups who underwent primary
amputation compared with revascularization or minor am-
putation initially. Therefore, although a clear algorithm
would help to make sense of our approach, we do not have
one. We have become more inclined to perform AKA in
patients with significant comorbidity, obesity, skin changes
related to edema or venous stasis that make a BKA flap
problematic, and poor albumin concentration. In addition,
we are now factoring the potential morbidity of rehabilita-
tion into the decision. Patients with poor balance with two
limbs, as a result of previous stroke, neuropathy, or artificial
joints, are considered for AKA. Patients with substance
abuse or mental illness are less likely to use a prosthesis.
Most important, we counsel our patients about realistic
post-amputation goals. Many patients remain adamant
about preserving the knee joint and firm in their belief that
they will regain bipedal gait. Usually BKA is technically
feasible, and we comply with their wishes.
Several disclaimers are in order. Clearly, we made some
clinical errors in attempting to salvage the knee joint in
patients with acute ischemia and failed limb salvage. Addi-
tional limitations relate to the partial retrospective nature of
the project, incomplete data for all patients, and the limited
numbers in subgroups raising the potential for type II
error. Nevertheless, our findings raise the question that
perhaps our results could be improved with better patient
selection based on risk factors, albumin concentration, and
hematocrit. Albumin concentration has been correlated
with hospital mortality and length of stay in several large
clinical series,33,34 and hematocrit has cardiovascular impli-
cations.
Finally, it is important to present alternative interpreta-
tions of our data. Clearly, if any significant prosthetic
ambulation is to be expected in this population, the knee
joint is necessary. However, current methods for predicting
prosthetic ambulation appear poor. Salvage of the knee
joint and a rigorous rehabilitation program have some
drawbacks in this population with a short life expectancy.
Community living with predominantly wheelchair ambula-
tion is currently the option for many vascular amputees,
with or without a knee joint. One could argue, Why ampu-
tate an extremity without obtaining detailed arterial ana-
tomic information to determine whether revascularization
and potential salvage is possible? We would counter, Why
attempt to salvage an extremity in all patients without proof
that they will benefit functionally, particularly when abbre-
viated life expectancy, nature of the foot wounds, long-
term pain issues, and premorbid function and comorbidity
are considered. We salvage extremities with lower extremity
revascularization, but our attempted bypass surgery–pri-
mary amputation ratio is probably lower than at many
centers. Over the 5 years of this study, critical limb ischemia
care at our center has evolved to minimize (1) the number
of patients who die early after bypass grafting without
ultimate incision and wound healing, (2) the number of
limbs eventually amputated after bypass grafting, despite
multiple attempts to either salvage a reconstruction or
forefoot amputation, or (3) both. The expense of this
approach is primary amputation of some limbs that, despite
substantial morbidity, could ultimately be salvaged. How-
ever, our approach has tended to minimize procedure-
related morbidity in the remaining months for patients with
end-stage systemic disease.
In summary, this report challenges traditional ap-
proaches to critical limb ischemia in patients facing ampu-
tation. Efforts to save the knee joint incur significant mor-
bidity in terms of delayed healing, wound complications,
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and eventual failure. In a population that is clinically and
physiologically severely ill, we found that a significant num-
ber of amputees are unable to regain bipedal gait despite
aggressive rehabilitation. In fact, some patients sustain sig-
nificant morbidity from attempted ambulation with pros-
theses as a result of falls and fractures. Despite a low rate of
postoperative ambulation, most patients remain living in
the community. Given the palliative nature of care in most
patients with critical limb ischemia, aggressive attempts at
salvaging the knee joint should be reserved for selected
patients at good risk.
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